Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Kirshner

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Journal of Virology|July 4, 2001
DNA binding by Kaposi's sarcoma-associated herpesvirus lytic switch protein is necessary for transcriptional activation of two viral delayed early promotersD M Lukac, L Garibyan, J R Kirshner, et al.
Annals of Surgery|September 1, 1983
Toward strategies for cost containment in surgical patientsW R Drucker, J W Gavett, R Kirshner, et al.
BMC Bioinformatics|July 22, 2016
In-silico discovery of cancer-specific peptide-HLA complexes for targeted therapyAnkur Dhanik, Jessica R Kirshner, Douglas MacDonald, et al.
Molecular Cancer Therapeutics|August 30, 2008
Elesclomol induces cancer cell apoptosis through oxidative stressJessica R Kirshner, Suqin He, Vishwasenani Balasubramanyam, et al.
Cancer Research|September 18, 2015
Dll4 Blockade in Stromal Cells Mediates Antitumor Effects in Preclinical Models of Ovarian CancerFrank Kuhnert, Guoying Chen, Sandra Coetzee, et al.
Molecular Cancer Therapeutics|January 22, 2017
Bispecific Antibodies and Antibody-Drug Conjugates (ADCs) Bridging HER2 and Prolactin Receptor Improve Efficacy of HER2 ADCsJulian Andreev, Nithya Thambi, Andres E Perez Bay, et al.
Clinical and Translational Science|January 8, 2022
Translational findings for odronextamab: From preclinical research to a first-in-human study in patients with CD20+ B-cell malignanciesMin Zhu, Kara Olson, Jessica R Kirshner, et al.
European Journal of Immunology|May 21, 2011
Ongoing Dll4-Notch signaling is required for T-cell homeostasis in the adult thymusFabienne Billiard, Jessica R Kirshner, Michelle Tait, et al.
Cancer Immunology Research|March 19, 2020
A PSMA-Targeting CD3 Bispecific Antibody Induces Antitumor Responses that Are Enhanced by 4-1BB CostimulationDanica Chiu, Richard Tavaré, Lauric Haber, et al.
Blood Advances|March 2, 2021
A BCMAxCD3 bispecific T cell-engaging antibody demonstrates robust antitumor efficacy similar to that of anti-BCMA CAR T cellsDavid J DiLillo, Kara Olson, Katja Mohrs, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Journal of Virology|July 4, 2001
DNA binding by Kaposi's sarcoma-associated herpesvirus lytic switch protein is necessary for transcriptional activation of two viral delayed early promotersD M Lukac, L Garibyan, J R Kirshner, et al.
Annals of Surgery|September 1, 1983
Toward strategies for cost containment in surgical patientsW R Drucker, J W Gavett, R Kirshner, et al.
BMC Bioinformatics|July 22, 2016
In-silico discovery of cancer-specific peptide-HLA complexes for targeted therapyAnkur Dhanik, Jessica R Kirshner, Douglas MacDonald, et al.
Molecular Cancer Therapeutics|August 30, 2008
Elesclomol induces cancer cell apoptosis through oxidative stressJessica R Kirshner, Suqin He, Vishwasenani Balasubramanyam, et al.
Cancer Research|September 18, 2015
Dll4 Blockade in Stromal Cells Mediates Antitumor Effects in Preclinical Models of Ovarian CancerFrank Kuhnert, Guoying Chen, Sandra Coetzee, et al.
Molecular Cancer Therapeutics|January 22, 2017
Bispecific Antibodies and Antibody-Drug Conjugates (ADCs) Bridging HER2 and Prolactin Receptor Improve Efficacy of HER2 ADCsJulian Andreev, Nithya Thambi, Andres E Perez Bay, et al.
Clinical and Translational Science|January 8, 2022
Translational findings for odronextamab: From preclinical research to a first-in-human study in patients with CD20+ B-cell malignanciesMin Zhu, Kara Olson, Jessica R Kirshner, et al.
European Journal of Immunology|May 21, 2011
Ongoing Dll4-Notch signaling is required for T-cell homeostasis in the adult thymusFabienne Billiard, Jessica R Kirshner, Michelle Tait, et al.
Cancer Immunology Research|March 19, 2020
A PSMA-Targeting CD3 Bispecific Antibody Induces Antitumor Responses that Are Enhanced by 4-1BB CostimulationDanica Chiu, Richard Tavaré, Lauric Haber, et al.
Blood Advances|March 2, 2021
A BCMAxCD3 bispecific T cell-engaging antibody demonstrates robust antitumor efficacy similar to that of anti-BCMA CAR T cellsDavid J DiLillo, Kara Olson, Katja Mohrs, et al.
Pageof 4